Hello Andrew,

Now that we’ve shown you our product offerings — Sleepio^Ⓡ for insomnia and Daylight^Ⓡ for anxiety — let’s discuss why managing and treating both sleep and anxiety is so important to the health of your workforce and your bottom line.

Sleep: The CDC reports that 18 million workers reported that sleep deficiency interfered with job performance.¹

Each year, insomnia costs employers:

• Over $5,000 in lost productivity costs per employee² 
• 7.8 lost work days for employees each year on average²

Anxiety: Nearly 20% of the US population have struggled with an anxiety disorder in just the past year.³

Each year, anxiety costs employers:

• Nearly $4,150 more in healthcare spend³ 
• Just under $8,800 in added workplace expenses³

These statistics are concerning and demonstrate the importance of addressing employees’ conditions before they progress. 

If you think we could be the right fit for your organization...

¹(Rodriguez, CDC declares sleep disorders a public health epidemic 2016)
²(Kessler et al., Insomnia and the performance of US workers: Results from the America Insomnia Survey 2011)

³Internal Data. (2023).

In accordance with FDA's Current Enforcement Discretion Policy for Digital Health Devices for Psychiatric Disorders, for patients who are followed by and diagnosed with insomnia disorder, generalized anxiety disorder or depression by a medical provider, Sleepio, Daylight and Spark Direct can be made available as an adjunct to their usual medical care for insomnia disorder, generalized anxiety disorder, or depression, respectively. Sleepio, Daylight and Spark Direct do not replace the care of a medical provider or a patient's medication. Sleepio, Daylight and Spark Direct have not been cleared by the U.S. Food and Drug Administration (FDA) for these indications. Users are directed to not make any changes to their prescribed medication or other type of medical treatment without seeking professional medical advice.